Neuroscience
Neurotransmitter receptors function via various G-protein coupled and G-protein independent mechanisms that activate downstream intracellular signaling pathways such as cAMP/PKA, PI3K/AKT, phospholipase A2, and phospholipase C pathways. For instance, dopamine receptors act through adenylate cyclase to activate PKA and other signaling molecules, thereby mediate gene expression through the actions of CREB and other transcription factors. Other neurotransmitters such as NMDAR or AMPAR are associated with ion channels that control flux of Ca2+ and Na+, thus propagating the action potential across the post-synaptic neuron.
Dysfunctions in GABAergic/glutamatergic/serotonergic/dopaminergic pathways result in a broad range of neurological disorders such as chronic pain, neurodegenerative diseases, and insomnia, as well as mental disorders including schizophrenia, bipolar disorder, depression, and addiction.
- B1601 Decamethonium BromideSummary: Nicotinic AChR partial agonist
- B1571 DesloratadineSummary: High affinity histamine H1 receptor antagonist
- B2236 DesvenlafaxineTarget: 5-HT Transporters|Norepinephrine transportersSummary: serotonin (5-HT) and norepinephrine (NE) reuptake inhibitor
- B2246 Desvenlafaxine SuccinateSummary: serotonin (5-HT) transporter and norepinephrine (NE) transporter reuptake inhibitor
- B1325 EUK 134Summary: Salen-manganese complexes;SOD mimetic
- B1573 Fexofenadine HClSummary: Histamine H1 receptor inhibitor
- B1592 Hexamethonium BromideSummary: Selective antagonist of neuronal-type nicotinic AChR
- B1561 Histamine 2HClSummary: Histamine receptor agonist
- B1603 Homatropine BromideSummary: Muscarinic AChR antagonist
- B1604 Homatropine MethylbromideSummary: Muscarinic AChR antagonist